Literature DB >> 1497477

Buspirone hydrochloride in the treatment of an atypical paraphilia.

J P Fedoroff1.   

Abstract

A case report involving buspirone hydrochloride in the successful treatment of a patient with an atypical paraphilia and transvestic fetishism is presented. Treatment outcome was assessed by the patient's self-report as well as by retrospective examination of detailed notes about paraphilia fantasies which unknown to the therapists, had been kept by the patient. Preliminary evidence indicates that buspirone appears to effectively treat some paraphilias.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1497477     DOI: 10.1007/bf01542028

Source DB:  PubMed          Journal:  Arch Sex Behav        ISSN: 0004-0002


  3 in total

1.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician.

Authors:  M F Folstein; S E Folstein; P R McHugh
Journal:  J Psychiatr Res       Date:  1975-11       Impact factor: 4.791

2.  Buspirone and transvestic fetishism.

Authors:  D A Fishbain
Journal:  J Clin Psychiatry       Date:  1989-11       Impact factor: 4.384

3.  Buspirone hydrochloride in the treatment of transvestic fetishism.

Authors:  J P Fedoroff
Journal:  J Clin Psychiatry       Date:  1988-10       Impact factor: 4.384

  3 in total
  4 in total

Review 1.  Current concepts in the pharmacotherapy of paraphilias.

Authors:  Frederico D Garcia; Florence Thibaut
Journal:  Drugs       Date:  2011-04-16       Impact factor: 9.546

2.  Is homosexuality a paraphilia? The evidence for and against.

Authors:  James M Cantor
Journal:  Arch Sex Behav       Date:  2012-02

Review 3.  Epidemiologic and clinical updates on impulse control disorders: a critical review.

Authors:  Bernardo Dell'Osso; A Carlo Altamura; Andrea Allen; Donatella Marazziti; Eric Hollander
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2006-09-07       Impact factor: 5.270

4.  Topiramate plus citalopram in the treatment of Compulsive-Impulsive Sexual Behaviors.

Authors:  Donatella Marazziti; Bernardo Dell'Osso
Journal:  Clin Pract Epidemiol Ment Health       Date:  2006-05-22
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.